Latest Press Releases
June 26, 2024
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
June 18, 2024
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
June 11, 2024
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
In the news
Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)
